Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADH1C | P00326 | 2/20 | 0.33 |
| ▸ | ADH1A | P07327 | 2/20 | 0.33 |
| ▸ | HRH4 | Q9H3N8 | 1/20 | 0.31 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.31 |
| ▸ | FAAH | O00519 | 1/20 | 0.31 |
| ▸ | PHGDH | O43175 | 1/20 | 0.31 |
| ▸ | MGLL | Q99685 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20063000 | 0.89 | ADH1C (0.31) | ADH1CADH1A | |
| SCHEMBL17053524 | 0.83 | ADH1A (0.41) | ADH1CADH1AHRH4HRH3FAAH | |
| SCHEMBL17053526 | 0.80 | ADH1A (0.37) | ADH1CADH1AHRH4HRH3FAAH | |
| SCHEMBL20062978 | 0.79 | ADH1A (0.35) | ADH1CADH1A | |
| SCHEMBL17053573 | 0.76 | ADH1A (0.39) | ADH1CADH1AHRH4HRH3FAAH | |
| SCHEMBL16639173 | 0.75 | ADH1A (0.35) | ADH1CADH1AHRH4HRH3FAAH | |
| SCHEMBL27966761 | 0.74 | ADH1A (0.39) | ADH1CADH1AHRH4HRH3FAAH | |
| SCHEMBL17053572 | 0.73 | ADH1A (0.36) | ADH1CADH1AHRH4HRH3FAAH | |
| SCHEMBL16639191 | 0.72 | ADH1A (0.37) | ADH1CADH1AHRH4HRH3FAAH | |
| SCHEMBL17053504 | 0.72 | ADH1C (0.32) | ADH1CADH1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10464953-B2 | Carbon bridged aminosilane compounds for high growth rate silicon-containing films | VERSUM MATERIALS US, LLC (US) | 2019-11-05 | — | — | US | disclosed |
| US-20180105541-A1 | Carbon Bridged Aminosilane Compounds for High Growth Rate Silicon-Containing Films | VERSUM MATERIALS US, LLC (US) | 2018-04-19 | — | — | US | disclosed |
| US-20180105541-A1 | Carbon Bridged Aminosilane Compounds for High Growth Rate Silicon-Containing Films | VERSUM MATERIALS US, LLC (US) | 2018-04-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180105541-A1 | Carbon Bridged Aminosilane Compounds for High Growth Rate Silicon-Containing Films | CCNA1, CCNB2, CCNA2 | ADH1C 4334/4885ADH1A 3534/4885HRH4 1398/4885 |
| US-10464953-B2 | Carbon bridged aminosilane compounds for high growth rate silicon-containing films | CCNA1, CCNB2, CCNA2 | ADH1C 4334/4885ADH1A 3534/4885HRH4 1398/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.